Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (371-380 of 753) with videos related to

Pageof 76
Sort By:
Anticancer Research|November 11, 2006
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancerR Torrisi, L Orlando, R Ghisini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
Cancer Treatment Reviews|November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunitiesAngela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancerG Pruneri, A Vingiani, V Bagnardi, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
International Journal of Clinical Oncology|April 12, 2014
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case seriesGaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
Breast Cancer Research and Treatment|April 28, 2004
Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trialBeat Thürlimann, Dagmar Hess, Dieter Köberle, et al.
Pageof 76

Showing results (371-380 of 753) with videos related to

Sort By:
Pageof 76
Anticancer Research|November 11, 2006
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancerR Torrisi, L Orlando, R Ghisini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
Cancer Treatment Reviews|November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunitiesAngela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancerG Pruneri, A Vingiani, V Bagnardi, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
International Journal of Clinical Oncology|April 12, 2014
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case seriesGaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
Breast Cancer Research and Treatment|April 28, 2004
Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trialBeat Thürlimann, Dagmar Hess, Dieter Köberle, et al.
Pageof 76